ResearcherTel Aviv UniversityActive in the last 2 years
Ido Laish
Matched on ORCID iD 0000-0003-0324-9998; OpenAlex author ID A5084081073. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 16
2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 4
- Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium. Co-author DOI 10.1002/ijc.70592↗
- Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adenocarcinoma. Last author DOI 10.1002/cam4.70144↗
- The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants. Co-author DOI 10.1002/cncr.35052↗
- Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.14309/ctg.0000000000000473↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Doron Yablecovitch · 3 shared papers, 2022–2026 · strength 0.53
- Paper Pancreatic Cancer Early Detection Biomarkers for High-Risk Individuals: Insights From the PRECEDE Consortium. DOI 10.1002/ijc.70592↗
- Paper Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adeno… DOI 10.1002/cam4.70144↗
- Paper Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma. DOI 10.14309/ctg.0000000000000473↗
- Talia Golan · 3 shared papers, 2022–2024 · strength 0.45
- Paper Serum matrix metalloproteinase-7, Syndecan-1, and CA 19-9 as a biomarker panel for diagnosis of pancreatic ductal adeno… DOI 10.1002/cam4.70144↗
- Paper The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants. DOI 10.1002/cncr.35052↗
- Paper Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma. DOI 10.14309/ctg.0000000000000473↗
- Christine Worthington · 1 shared paper, 2026 · strength 0.24
- Giulio Innamorati · 1 shared paper, 2026 · strength 0.24
- Diane M. Simeone · 1 shared paper, 2026 · strength 0.24
- Thomas Martin Wilkie · 1 shared paper, 2026 · strength 0.24
- Randall E. Brand · 1 shared paper, 2026 · strength 0.24
- George Zogopoulos · 1 shared paper, 2026 · strength 0.24
- Jennifer B. Permuth · 1 shared paper, 2026 · strength 0.24
- Julie Earl · 1 shared paper, 2026 · strength 0.24
- Phil A. Hart · 1 shared paper, 2026 · strength 0.24
- Rinat Bernstein‐Molho · 1 shared paper, 2024 · strength 0.16
- Guy Rosner · 1 shared paper, 2024 · strength 0.16
- Zohar Levi · 1 shared paper, 2024 · strength 0.16
- Elizabeth Half · 1 shared paper, 2024 · strength 0.16
- Erez Hasnis · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.